CD14 and psoriasis: This may reflect in vivo pre-activation or an exhausted state of BDCA-4+CD14+ cells in psoriasis, leading to decreased BDCA-4 expression upon subsequent TLR7/9 stimulation, potentially through negative feedback, receptor internalization, or transient differentiation/redistribution into other subtypes.